Opinicus Capital’s Merck MRK Stock Holding History
Bought
Maintained
Sold
Other funds holding MRK
Opinicus Capital's MRK Position: Q3 2026 in Review
Opinicus Capital reduced its Merck (MRK) stake by 1.5% in Q3 2026, selling an estimated $24.6K and leaving 11,486 shares worth $1.67M. The position accounts for 0.9% of the portfolio, ranked #33.
Opinicus Capital first reported a position in MRK in Q4 2023 and has held it in 12 quarters since. 1,788 funds tracked by Wall St. Rank hold MRK as of Q3 2026.
- Opinicus Capital held 11,486 shares of Merck worth $1.67M as of Q3 2026.
- Opinicus Capital sold 178 Merck shares in Q3 2026, an estimated $24.6K.
- Merck made up 0.9% of Opinicus Capital's portfolio in Q3 2026, its #33 holding.
- Opinicus Capital first reported a position in Merck in Q4 2023 and has held it in 12 quarters since.
- 1,788 funds tracked by Wall St. Rank held Merck as of Q3 2026.
Based on Opinicus Capital's 13F filing for Q3 2026, filed 28 Oct 2026.